Entertainment Wire Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.

Press releases published on May 14, 2026

May 14, 2026

Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors

Indeterminate GlobeNewswire

May 14, 2026

NORTIV 8 Awarded “Hiking Shoe Product of the Year” In 2026 Outdoor Innovation Awards Program

Indeterminate GlobeNewswire

May 14, 2026

Merlin Unveils Plans for AI-Powered Autonomy for Commercial Cargo Aircraft

Indeterminate GlobeNewswire

May 14, 2026

ElevateBio Data at ASGCT 29th Annual Meeting Showcase Expanded Gene Editing Platform and Services Spanning New Modalities, AI Discovery, and LNP Delivery

Indeterminate GlobeNewswire

May 14, 2026

Merlin, Inc. Reports First Quarter 2026 Results

Indeterminate GlobeNewswire

May 14, 2026

EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data

Indeterminate GlobeNewswire

May 14, 2026

Destination XL Group, Inc. to Announce First Quarter 2026 Financial Results on Thursday, May 28, 2026

Indeterminate GlobeNewswire

May 14, 2026

Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire

May 14, 2026

Akamai Technologies Announces Intent to Acquire LayerX, Advancing Its Workforce Security Strategy with AI Usage Control

Indeterminate GlobeNewswire

May 14, 2026

CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder

Indeterminate GlobeNewswire

May 14, 2026

Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease

Indeterminate GlobeNewswire

May 14, 2026

Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting

Indeterminate GlobeNewswire

May 14, 2026

The Post-Quantum Migration Window Just Got a Lot More Practical: QPA v2 Lands at the Enterprise Tier

Indeterminate GlobeNewswire

May 14, 2026

Year Six of the Silver Deficit Meets a Newly Funded Critical-Metals Drill Program in British Columbia

Indeterminate GlobeNewswire